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Abstract
Oxygen is a key modulator of many cellular pathways, but current devices permitting in vitro oxygen modulation fail to
meet the needs of biomedical research. A microfabricated insert for multiwell plates has been developed to more effectively
control the temporal and spatial oxygen concentration to better model physiological phenomena found in vivo. The platform
consists of a polydimethylsiloxane insert that nests into a standard multiwell plate and serves as a passive microfluidic gas
network with a gas-permeable membrane aimed to modulate oxygen delivery to adherent cells. Equilibration time is on the
order of minutes and a wide variety of oxygen profiles can be attained based on the device design, such as the cyclic profile
achieved in this study, and even oxygen gradients to mimic those found in vivo. The proper biological consequences of the
device’s oxygen delivery were confirmed in cellular models via a proliferation assay and western analysis of the upregulation
of hypoxia inducible transcription factor-1a. These experiments serve as a demonstration for the platform as a viable
tool to increase experimental throughput and permit novel experimental possibilities in any biomedical research lab.
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Introduction
Oxygen is a key metabolic variable influencing many different
biological phenomena; however, current tools to probe this
variable are either crude, inefficient, or have not changed since
the dawn of cell culture techniques. Oxygen is increasingly
implicated in many signaling pathways and one route of
modulation is through the hypoxia-inducible factor (HIF) family
of heterodimeric transcription factors, which regulate the cellular
response to oxygen tension [1]. HIF-1a is a ubiquitous
transcription factor that has been found to influence development,
glucose metabolism, apoptosis, solid tumor growth, and angio-
genesis, among many other functions [2]. Enabling a simple tool to
explore these cellular behaviors would greatly facilitate these
investigations and accelerate scientific discovery.
Tissues are often exposed to complex oxygen concentrations
spatially and temporally in vivo, which addresses the requirement
for a device that has defined control over the oxygen environment
exposed to cells in vitro. Gradients of oxygen are standard
byproducts of cellular metabolism found throughout every tissue
and across all organisms. These gradients of oxygen are
increasingly highlighted as crucial metabolic regulators when
studying drug toxicity [3,4], the hematopoietic stem cell niche [5],
plant biology [6,7], liver zonation [8,9], and throughout
developmental biology [10,11]. Intermittent hypoxia, or cycling
oxygenation, has been shown to be important in a number of
pathological conditions, such as in sleep apnea [12] and tumor
development [13]. These studies have demonstrated that cells do
indeed respond differently to variable oxygen levels as opposed to
constant oxygenation, and often times the former is more
pathological. Thus, replicating both these in vivo gradients and
transient oxygenation in an in vitro model accessible to any
standard cell biology lab would have a huge impact across many
fields.
The hypoxic chamber remains as the tool of choice and has seen
a great deal of use in applications requiring control over the
oxygen tension exposed to cells due to its ease of use and no
requirement for specialized equipment for its operation [14,15,16].
However, the device fails to satisfy the needs of biomedical
researchers to efficiently modulate oxygen tensions rapidly and
over multiple conditions as a separate chamber is required per
condition. Several groups have developed devices for controlling
the oxygen tension experienced by cell cultures that are aimed to
improve upon the hypoxic chamber [3,17,18,19,20,21]. Despite
advancements in system equilibration time and the ability to
establish oxygen gradients, many of these devices require very
specific parameters for operation, including the need for complex
fluid handling and often times electric controls [20]. The
requirement of specialized knowledge and equipment for their
use is unattractive to many labs.
A new device with more precise temporal and spatialcontrolover
gas concentrations experienced by the cell, while possessing a
smaller lab footprint than many other current cell oxygenation
devices, could be very beneficial to the scientific community. To
meet this demand a new device has been fabricated consisting of a
polydimethylsiloxane (PDMS) insert that nests into a standard
multiwell plate as shown in figure 1a. The insert contains a series of
pillars matching the number and spacing of wells of the plate it is
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6891designed to nest into. A 6-well version was used for proof of concept
purposes; however, the strategy can be easily expanded to higher
density multiwell plates (e.g. 12, 24, 48 or 96-wells) as shown in
figure 1b. Oxygen is injected through microchannels embedded at
the base of each pillar and is separated from the fluidic contents of
the culture well by a 100 mm gas-permeable PDMS membrane, as
shown in a schematic cross-section of the device in figure 1c. The
bottom of the membrane can be fixed at various distances from the
substrate of the well by employing spacers or altering the length of
the pillar. The oxygen microchannels connect to conventional gas
cylinders which provide the pressure to deliver the gas throughout
theinsert.Theinsertacts asa sinkorsource ofoxygendepending on
the concentration of the oxygen in the microchannels, and is
immersedinthecellculture mediumofthe well.Thegasisdelivered
to the cell monolayer through simple diffusion of oxygen across the
PDMS membrane and dissolves into the culture media of the
multiwell plate. The cultured cells are never in contact with gas and
hence issues with gas bubbles disrupting the integrity of the cell
membrane are avoided. The oxygenation routing and pillar
microchannels are fabricated through standard soft lithographic
techniques [22] and the pillar array is fabricated through casting
PDMS into a machined Delran mold. Figure 1c also depicts the cell
monolayer at the bottom of the well positioned approximately
200 mm from the bottom of a pillar. This close spacing between the
PDMS membrane and cell monolayer allows for rapid diffusion to
impose steady state gradients of oxygen across the well within
minutes and is not altered by the slight deflection of the elastomeric
flexible membrane as indicated by figure 2. Many oxygenation
profiles can be generated depending on the layout of the
microfluidic oxygenation channels at the base of the pillar.
PDMS is used as the material of the insert due to its optical
clarity, gas permeability (Doxygen in PDMS=3 610
25 cm
2/s), and
ease of rapid prototyping. However, several recent studies have
highlighted the ability of PDMS to absorb water and hydrophobic
soluble factors [23,24,25,26]. Only the membrane component of
our platform needs to be made with PDMS due to its excellent
oxygen permeability and the bulk of our platform (including the
gas microchannels and pillar array) can be fabricated with
alternative polymers more resistant to hydration and absorption
such as polymethylmethacrylate, cyclic olefin copolymer, or
polycarbonate. Our initial studies rely on PDMS due to the ease
of rapid prototyping and have taken measures to avoid hydration
of the manifold from altering the experimental conditions. Water
loss through absorption into PDMS would be detrimental in cell
culture that relies on specific concentrations of solutes to maintain
pH and nutrient levels. Specifically the device is pre-hydrated
through immersion in cell media or water prior to experimenta-
tion. While PDMS is not an ideal material for cellular studies,
these measures can be taken to improve its functionality.
Results
PDMS membrane deflection is negligible
Due to the small gap size between the device and cells, the
deflection of the PDMS membrane due to gas infusion pressure
needed to be assessed, as shown in figure 2. The device was laid on
Figure 1. Schematic and diagrams illustrating device features. The oxygen insert device is fabricated by conventional photolithography
(microfluidic network), replica molding (microfluidic network and insert scaffold), and defined spinning of PDMS (gas-permeable membrane). A) The
oxygen device nested into a 6-well plate. B) Examples of 24 and 96-well pillar arrays. C) A cross-sectional schematic of a pillar. Oxygen flows into the
device through the inlet and travels across a microfluidic network at the bottom of the pillar. Oxygen can freely diffuse across the gas-permeable
PDMS membrane at the bottom of the pillar and dissolve into the culture media. D) A macroscope image showing the various features of a single-
channel pillar from above, with bonded glass posts for the equilibration studies.
doi:10.1371/journal.pone.0006891.g001
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expected, deflection distance was inversely proportional to PDMS
membrane thickness and directly proportional to oxygen flow rate.
This data indicated that the PDMS membrane deflection is
negligible as the device’s operational flow rates (80 mL/min for
initial equilibration and 25 mL/min for concentration mainte-
nance) do not deflect the membrane enough for contact with the
underlying cells. Even at the highest flow rate (250 mL/min) and
100 mm thickness, the membrane would still only deflect less than
15% of the distance to the cells.
Device oxygen concentration validation
A planar ruthenium fluorescence oxygen sensor (FOXY slide)
was used for quantifying the oxygen concentration at the well
substrate. The fluorescence of the ruthenium complex is quenched
in the presence of oxygen, thus oxygen concentration can be
calculated via measurement of fluorescent intensity. The 0%
oxygen equilibration experiments demonstrated that the device
can rapidly change the oxygen concentration at the well substrate
as shown in figure 3a. For a membrane-well bottom spacing of
0.2 mm, the device equilibrated to less than 0.5% oxygen in about
1.5 min. Equilibration took slightly longer and was less complete
for the 0.5 mm spacing, taking about 5 min to achieve roughly 1%
oxygen. For the 1 mm spacing, the device equilibrated to
approximately 2% oxygen in about 15 min. Equilibration for
the hypoxic chamber was orders of magnitude slower, taking
about 3 h to reach approximately 2.5% oxygen which is in
agreement with previously published data [27]. Figure 3b depicts
the rapid response of the oxygen concentration at the bottom of
the well when switching between two oxygenation conditions,
which is not possible with the standard hypoxic chamber due to
long equilibration times.
Intensity measurements were also taken across the width of the
channel at specific positions to ensure homogeneity of oxygen
concentrations across the well. For the single channel device,
infused 0%, 10%, and 21% oxygen were measured at 20 min as
shown in figure 3c. The oxygen concentration maintained good
homogeneity with no considerable increase near the microchannel
boundary. The device was also tested for maintenance of 10%
oxygen over 5 days as shown in figure 3d. After the initial baseline
point, all measurement time points yielded 10% oxygen without
prolonged immersion in media altering the delivered oxygen.
Devices were also fabricated with more complex microchannel
designs, which provided enhanced spatial control over the
oxygenation across the well. A dual-microchannel device effec-
tively maintained both 0% and 21% oxygen across a single well for
14 days as shown in figure 4a, again demonstrating that media
diffusion into the pillar did not adversely affect the oxygen
concentration.
To push the limits of this approach, a cyclic oxygenation profile
was demonstrated across a single well as shown in figure 4b. While
the device was unable to generate the minimum and maximum
conditions as close as the single condition device as shown in
figure 3, the device did successfully generate distinct oxygenation
zones with a gradient of oxygen tension separating each zone. The
diffusion of gas from one microchannel to the next was minimized
by maintaining the gas flow rate much higher than the oxygen
diffusion rate. These initial demonstrations can be used as a
starting point for many other complex oxygen profiles to expand
the number of experimental possibilities for the biomedical
researcher.
Common sterilization methods do not alter device gas
delivery
Since the device will be used for cell culture experiments,
sterilization is required before its application. Four sterilization
methods were used to assess the affect of sterilization on diffusion
of oxygen through the membrane. No significant difference was
observed between any of the sterilization methods and the control
condition after 32 cycles, demonstrating that the device can be
sterilized without altering its function as shown in figure 5.
Cellular proliferation and transcription factors are
modulated with the device
The device’s ability to modulate cellular behavior including
proliferation and HIF-1a expression was also investigated to
validate the device’s compatibility with standard cell culture
techniques. The device successfully regulated human dermal
fibroblast proliferation as shown in figure 6a. As expected,
proliferation was highest in 10% oxygen [28,29]. No cells survived
after 4 days in 0% infused oxygen.
For qualifying HIF-1a expression in human osteosarcoma cells
(U2OS) using Western analysis, cell lysate was immediately
extracted after removal of the hypoxic insert device. Lysate
protein was separated on an SDS-PAGE gel and transferred to a
membrane for immunoblotting using the H1a67 primary
antibody. Western analysis confirmed that HIF-1a was upregu-
lated in cells exposed to hypoxia as compared to the 21% oxygen
control cells as shown in figure 6b. These experiments using
cellular models affirm that the device functions appropriately for in
vitro cell experiments.
Discussion
As the data demonstrate, the hypoxic insert device is effective at
both controlling the temporal and spatial concentration of oxygen
in a 6-well plate. Fast equilibration time and complex oxygen
concentration patterning based on the microchannel design
expands the experimental possibilities to include studies not
possible with conventional technologies. In this study, several
oxygen concentration profiles were achieved and many more are
Figure 2. Deflection of PDMS membranes of varying thick-
nesses. Deflection distance was inversely proportional to membrane
thickness, with the 100 mm membrane deflecting the most and the
230 mm membrane deflecting the least. The data indicates that
deflection of the 100 mm is negligible for operational flow rates
(,25 mL/min) relative to the overall gap distance between the
membrane and cells.
doi:10.1371/journal.pone.0006891.g002
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As mentioned previously, the gold standard for hypoxia exposure
is the hypoxic chamber, which takes hours to equilibrate, cannot
achieve extremely hypoxic regimes (,2%), and only permits a
single oxygen concentration within the same cell population.
However, the device presented here reduces the equilibration time
by orders of magnitude, yields concentrations below 0.5% oxygen,
and permits very complex oxygen profiles across the same well. It
is important to note these experiments did not contain cells, which
would further deplete the available oxygen. Future improvements
of the device are planned, including on-device custom gas mixing,
media perfusion ports for slow exchange of cell media, and
secondary gas ports for areas surrounding the pillar. Finally, the
current device iteration was used with 6-well plates, but our lab is
designing devices for use in 12, 24, and even 96-well plates to
increase experimental throughput, in addition to Petri dishes and
larger scale culture vessels.
In addition to general in vitro studies involving control over gas
concentration, the hypoxia insert device is particularly advanta-
geous for the enormous gamut of applications requiring transient
effectsorcomplex oxygen profiles.Ischemiareperfusioninjury,asin
the case of cardiac (myocardial infarction) or cerebral (stroke) tissue,
is one such research application of the device due to its highly
effective temporal control over oxygen concentration, permitting
more accurate investigation of the causes for tissue necrosis post-
reperfusion. Other topics benefiting from the more rapid equili-
bration response of the device include sleep apnea and cancer cell
research. In fact, hypoxia and activation of the HIF-1a pathway are
characteristic of many types of tumors [30] and can be indicative of
tumor aggressiveness [31]. More recently, intermittent hypoxia has
been shown to induce elevated levels of HIF-1a transcription [32]
and tumor invasiness [13] over continuous hypoxia. Thus cyclic
reoxygenation plays a role in cellular response to hypoxia and faster
system oxygen concentration response time would expand the
Figure 3. Validation of the device with oxygen sensors. Oxygen tension within each well was characterized using a planar ruthenium oxygen
sensor. All oxygen mixtures contained balanced nitrogen and 5% CO2 for media buffering. A) Plot illustrating the effect of post height, and thus
oxygen diffusion distance between the membrane and cells, on the equilibration time and effectiveness. Heights were established by cut-glass posts
bound to the bottom of the device. All three post sizes yield equilibration times much improved over the hypoxic chamber. Note that time is on a log
scale. B) Plot depicting the rapid oxygen equilibration response time of the 0.2 mm gap device. C) Multi-position linescans were also taken across the
well under the microchannel to ensure homogeneity of the oxygen concentration introduced by the device. Graph depicts the oxygen concentration
measured after infusing 0%, 10%, and 21% oxygen for 10 min. D) Device effectively maintains 10% oxygen over 5 days.
doi:10.1371/journal.pone.0006891.g003
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benefiting from the ability to generate complex oxygen gradients
include but are certainly not limited to liver zonation, stem cell
niche, drug toxicity, and developmental biology. The number of
experiments that will benefit from enhanced spatial and temporal
control over oxygen concentration offered by the hypoxia device is
substantial and will likely extend to new areas of research that were
either too difficult to conduct with the current technologies or were
simply not possible.
Materials and Methods
Device fabrication
The oxygen insert device was fabricated using common soft
lithography techniques in a 3-step process: 1) gas-permeable
membrane, 2) the microfluidic network, and 3) the insert scaffold
as shown in figure S1a. The overall pillar length was tailored to
achieve a desired height separation between the bottom of the
membrane and the seeded cells, depending on the experiment.
The 100 mm-thick gas-permeable PDMS membrane was made
by spinning premixed 10:1 ratio of PDMS prepolymer and curing
agent (Sylgard 184 kit, Dow Corning) on a thoroughly cleaned
silicon wafer vacuum-adhered to a precision spinner (Laurel). The
dependence of PDMS thickness on spin speed and duration is
depicted in figure S1b. The PDMS-coated wafer was spun at 500
RPM for 10 seconds to initially spread the PDMS droplet, and
then 900 RPM for 30 seconds to attain the desired thickness. The
PDMS-coated wafer was then placed on top of a leveled hot plate
set to 75uC and heated for two hours to cure the PDMS. After
curing, a small circle of PDMS is removed from the wafer-adhered
sheet and placed on top of a transparency film to facilitate
handling when bonding to the device.
The microfluidic network was designed in AutoCAD and
printed onto high resolution (5080 dpi) transparencies (Fineline
Imaging). The transparency is used as a photomask to selectively
crosslink a photoresist prespun to a desired thickness on a silicon
wafer. Briefly, SU-8 2150 photoresist (Microchem) was spun to
achieve a thickness of 200 mm in accordance to the manufacturer’s
protocol. This resist was then selectively exposed to UV light
through the photomask to selectively polymerize the SU-8. Finally,
uncross-linked regions of the photoresist were removed by washing
the wafer in SU-8 developer solution. Once the SU-8 negative
mold master was fabricated, PDMS was poured onto the master to
generate a positive mold at the desired thickness. The PDMS
mixture was cured for 2 hours at 75uC. Once cured, a section the
size of the device pillar was removed from the molded PDMS.
The actual insert scaffold component of the device was
fabricated by molding in a machined polycarbonate scaffold as
shown in figure S1c. The PDMS was cured overnight in a
convection oven set to 75uC.
After fabrication of the three components was completed, the
device itself was ready to be assembled. First, the insert component
and the microfluidic network component were bonded after
surface exposure to oxygen plasma and 1 h incubation. For the 6-
well plate device, 6 microfluidic network components were bonded
to the 6 pillars of the insert. Then, a cork-borer was used to
puncture holes connecting the top of the insert component to the
bottom of the microfluidic network component. These vias
Figure 4. Experimentation with more complex oxygen microchannel designs. A) Dual-condition microchannel setup yields a stable 0% and
21% oxygen profile over 14 days. B) An interdigitated and winding pattern of 500 mm width microchannels extending across the pillar results in a
cyclic oxygen profile. Note that the data only depicts one representative trial as microchannel alignment was difficult.
doi:10.1371/journal.pone.0006891.g004
Figure 5. Common sterilization methods do not alter device’s
ability to deliver oxygen. An important aspect of any cell culture
tool is the ability to sterilize it without the loss of function. Four
separate devices were exposed to each of the commonly available
sterilization methods over 32 cycles, with an untreated control. The
oxygen concentration at the bottom of the well was measured with the
fluorescent oxygen probe with infused 10% O2 on cycle 1, 2, 8, 16, 24,
and 32. No sterilization method had a significant effect on device
function compared to control.
doi:10.1371/journal.pone.0006891.g005
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device. Then, the insert/microfluidic network component and
membrane component were bonded after exposure to oxygen
plasma and incubated for 1 h. For some of the oxygen validation
studies, cut glass posts from coverslips or microscope slides were
bonded to the membrane under the periphery of the microchannel
to alter the spacing between the substrate of the pillar and the
substrate of the well. Note that glass posts were utilized only for the
validation studies so that the same pillar mold (and thus length)
could be used for a variety of gap sizes. The pillar length
determines the media diffusion distance in the functional version
of the device.
PDMS membrane deflection
Due to the small gap size between the device and cells, the
deflection of the PDMS membrane due to gas infusion pressure
needed to be assessed. Three different devices were made to
examine the effect of PDMS membrane thickness on deflection.
Each membrane thickness was examined with four different
infused oxygen flow rates. The device was laid on its side and
deflection distance was measured using microscopy (see micro-
scope system information in the following oxygen concentration
validation section).
Oxygen concentration validation in the device
FOXY slides (FOXY-SGS, Ocean Optics) were used for
quantifying the oxygen concentration at the well substrate [33].
Recall that the oxygen concentration is inversely proportional to
the fluorescent intensity of the slide. Briefly, the slide was placed in
the wells of a 6-well plate, simulating where the cells would be
present. Oxygen concentrations of 0%, 10%, and 21% (5% CO2,
balanced nitrogen tanks) were introduced into the channels of the
device and oxygen concentration was measured via fluorescence.
Note that 5% CO2 is needed for culture media pH buffering.
However, cells were not used in these validation studies in order to
test the functionality of the device alone, as metabolic oxygen
uptake can vary dramatically between cell types and density.
A fluorescence-equipped Olympus IX71 microscope, charged-
coupled device camera (QImaging Retiga-SRV) and SlideBook
image acquisition software (v4.2.0.9) were used for capturing
images. All images were acquired at room temperature using a
FOXY-compatible fluorescent filter (Olympus 31020) with an
excitation wavelength of 475 nm and emission wavelength of
600 nm. Images were taken at 10X (UPlanSApo 10x/0.40) for all
experiments except for the cyclic profile device, where images
were captured at 2X (PlanApo 2x/0.08). A motorized stage (Prior
ProScan II) with x, y, and z control was used to store and return to
previous image capture locations. A 75W Xenon burner (Olympus
U-LH75X) was used to illuminate the FOXY slides. Image
intensities were exported using SlideBook for later analysis. DI
water was used as the diffusion medium for FOXY experiments.
To establish a calibration curve at each slide position, a device
without the membrane was placed directly against the FOXY slide
so that the bottom of the microchannel was the fluorescence
oxygen sensor itself. Thus, the slide was directly exposed to the
introduced oxygen without the media and membrane in the
diffusion path. Two linear curve equations were fitted to the three
data points using Microsoft Excel; one from 0% to 10% percent
oxygen, and the other from 10% to 21% oxygen. This method
proved to be more accurate than using a second degree
polynomial curve fit as described by the manufacturer, which
tended to underestimate lower oxygen concentrations.
For the 0% oxygen equilibration studies, slide-membrane
separations of 0.2 mm, 0.5 mm, and 1.0 mm were used to assess
the effect of oxygen diffusion distance on measured oxygen
concentration at the well surface. The height separation was
Figure 6. Validation of the device with cellular models. A) Human adult dermal fibroblast cells were used as a cellular model to study
proliferation in response to oxygen concentrations established by our device. Cells were seeded in the wells of a 6-well plate and cultured to
confluency. The device was removed from the plate at 24, 48, 72, and 96 h to briefly exchange the culture media and to take images of the cells for
later cell counting. The plot depicts the proliferation of cells. Data is presented as cell number normalized to baseline (day 0) over the course of 4 days
for cells continually exposed to 0%, 10%, and 21% O2. Proliferation was highest in 10% O2 (as expected). No cells survived after 4 days in 0% infused
oxygen. B) Human osteosarcoma cells (U2OS) were seeded in a 6-well plate to ,85% confluency and exposed to hypoxia and normoxia for 24 h
using the hypoxic insert device. Control cell media was supplemented with 10 mM CoCl2, which mimics the hypoxic state and results in HIF-1a
upregulation [27]. Cells cultured in atmospheric oxygen without exposure to the device served as the device control (DC). Western analysis was used
to qualify regulation of HIF-1a expression. The figure depicts upregulation of HIF-1a in cells exposed to hypoxia using the device, relative to the no
device control and 21% oxygen. The device 0% oxygen band intensity is comparable to the CoCl2 control.
doi:10.1371/journal.pone.0006891.g006
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pillar. The overall pillar length was made longer to ensure that the
post height was actually determining the diffusion distance and the
pillarwasnotmerely suspended from the topof thewell. 0%oxygen
was introduced into the channel and fluorescence intensity
measurements were taken every 10 seconds for 30 min. A hypoxic
chamber was also used as a comparison to demonstrate the
effectiveness of the device. Briefly, the hypoxic chamber was rapidly
flushed with 0% oxygen and then a steady influx of 0% oxygen was
maintained for 3 h. Intensity measurements were taken every
minute and reflected the average intensity value of the entire image
Multi-position linescans were also taken across the well under
the microchannel to ensure homogeneity of the oxygen concen-
tration. Infused oxygen concentrations of 0%, 10%, and 21% were
measured after 20 min in the device. The ability to maintain 10%
oxygen over 5 days was also examined using the same setup as for
the other linescans.
One important feature of the device is the ability to precisely
controlthe spatial oxygenconcentration acrossthe well by changing
the design of the microchannel at the bottom of the pillar. A dual-
channel device was fabricated to validate the effect of two
concentrations across a single well. Oxygen concentrations of 0%
and 21% oxygen were introduced into the channels of the device
and oxygen concentration was measured via fluorescence across the
well at fixed positions similarly to the above experiments. The
experiment was run for 14 days to evaluate the effect of media
diffusion into the device on oxygen concentration.
A cyclic profile device was also fabricated to validate the ability of
the device to generate complex profiles across a well. Two
interdigitated and winding microchannels of 500 mm width
extended across the pillar to generate a cyclic oxygen profile using
two of the three oxygen concentrations available at a time. Four
images at 2X that spanned the entire well were captured, linescans
were taken across each image, and the exported intensity data was
stitched together. Note that the linescan reflects the inhomogeneity
of the ruthenium embedded in the FOXY slide more than previous
quantifications which averaged over a larger area for a single value.
Effect of common sterilization methods on the device
An important aspect of any cell culture tool is the ability to
sterilize it without the loss of function. Four sterilization methods
were used to assess the affect of sterilization on diffusion of oxygen
through the membrane: 1) Autoclave at 121uC for 15 min, 2) Soak
in Dri-Clean detergent at 52uC for 15 min, 3) Soak in 70% ethanol
for 15 min, 4) Exposure to culture hood ultraviolet sterilization light
at 253.7 nm for 2 h. Four separate devices were exposed to each of
the sterilization methods over 32 cycles. The oxygen concentration
at the bottom of the well was measured with the fluorescent oxygen
probe at 10% oxygen on cycle 1, 2, 8, 16, 24, and 32.
Effect of oxygen concentration on fibroblast proliferation
Human adult dermal fibroblast cells (Sciencell) were used as a
cellular model to study proliferation in response to oxygen
concentrations established by our device in a 100 mm diffusion
gap configuration. Cells were expanded in fibroblast culture media
supplemented with 2% Fetal Bovine Serum, 1% Penicillin/
Streptomycin, and 1% Fibroblast Growth Serum (Sciencell).
Fibroblasts were seeded into the wells of a 6-well plate at a
density of 2.5610
3 cells/cm
2. Media was then changed the next
day immediately prior to introduction of 0%, 10%, and 21%
oxygen into the device. Experiments were conducted in a
humidified incubator (95% relative humidity, 37uC) to prevent
media evaporation and maintain proper physiological tempera-
ture. The insert was removed from the plate at 24, 48, 72, and
96 h to briefly exchange the culture media and to take images of
the cells for later cell counting. Once the media was changed and
five brightfield microscopy images per well were taken, the cell-
seeded plate was placed back into the culture incubator and the
experiment was continued. Cells were later counted using the
acquired images.
Western analysis of HIF-1a
In order to test the physiological relevance of the hypoxic setup,
U2OS cells were plated at 80% confluency in DMEM media
supplemented with 10% Fetal Bovine Serum and Penicillin/
Streptomycin. The cell-seeded plate was placed in the incubator
and the device was nested and exposed to either 21% or ,0.5%
oxygen. After 24 hours, cells were harvested immediately in lysis
buffer (1 mM EDTA, 0.15 M NaCl, 0.05 M Tris-Hcl, 0.5%
Triton-X) and placed in dry ice in order to preserve protein
integrity. Fifty mg of protein lysate was separated on an 8% SDS-
PAGE gel and HIF-1a was detected using the mouse monoclonal
H1alpha67 antibody (Abcam, Cambridge Massachusetts, 1:1000).
U2OS cells treated in 10 mM CoCl2 for 24 hours serves as a
control as CoCl2 has been previously shown to mimic the hypoxic
state and as a result cause induction of HIF-1 m [27].
Statistical analysis
All experiments were conducted at least three times for proper
statistical analysis unless otherwise noted in the text. Graphs depict
the average value with the error bars indicating standard
deviation.
Supporting Information
Figure S1 Fabrication of the device. Polydimethylsiloxane
(PDMS) is used for the device due to its biocompatible,
moldability, and most importantly, gas-permeability. A) Overall
schematic of the fabrication process. The oxygen microfluidic
channels are fabricated using standard SU-8 photolithography.
PDMS is then replica molded from the negative SU-8 master to
create the microfluidic network. For the oxygen validation studies,
cut glass posts were bonded to the bottom of the device outside of
the microchannel area for precise establishment of diffusion
distance. B) The gas-permeable membrane is made by precision
spinning PDMS prepolymer mix to 100 A ˆmm. C) The pillar array
is casted in a polycarbonate mold.
Found at: doi:10.1371/journal.pone.0006891.s001 (1.00 MB
DOC)
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